Developmental expression of cellular prion protein and apoptotic molecules in the rat cerebellum: Effects of platinum compounds

Journal of Chemical Neuroanatomy

Volumn 46, Issue 1-2, 2012, Pages 19-29

  Bottone, Maria Grazia ^a,b   Veronica, Dal Bo ^a   Piccolini, Valeria Maria ^a   Bottiroli, Giovanni ^b   De Pascali, Sandra Angelica ^c   Fanizzi, Francesco Paolo ^c   Bernocchi, Graziella ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF SALENTO   (Italy)

Author keywords

Bax; Bcl 2; Cellular prion protein; Neuroprotection; Platinum compounds

Indexed keywords

CISPLATIN; PLATINUM DERIVATIVE; PRION PROTEIN; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL TISSUE; ANTIBODY LABELING; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CEREBELLUM; CEREBELLUM CORTEX; CONTROLLED STUDY; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PURKINJE CELL; RAT;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CEREBELLUM; GENE EXPRESSION REGULATION, DEVELOPMENTAL; PLATINUM COMPOUNDS; PRPC PROTEINS; RATS; RATS, WISTAR; TREATMENT OUTCOME;

EID: 84870719561     PISSN: 08910618     EISSN: 18736300     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2012.09.003     Document Type: Article

References (60)

1. Ahmad S. Platinum-DNA interactions and subsequent cellular processes controlling sensitivity to anticancer platinum complexes. Chemistry & Biodiversity 2010, 7:543-566.
2. Akhtar R.S., Ness J.M., Roth K.A. Bcl-2 family regulation of neuronal development and neurodegeneration. Biochimica et Biophysica Acta 2004, 1644:189-203.
3. Allsopp T.E., Wyatt S., Paterson H.F., Davies A.M. The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 1993, 73:295-307.
4. Altman J. Postnatal development of the cerebellar cortex in the rat. I. The external granular layer and the transitional molecular layer. Journal of Comparative Neurology 1972, 145:353-398.
5. Altman J. Postnatal development of the cerebellar cortex in the rat. II. Phases in the maturation of Purkinje cells and of the molecular layer. Journal of Comparative Neurology 1972, 145:399-464.
6. Avella D., Pisu M.B., Roda E., Gravati M., Bernocchi G. Reorganization of the rat cerebellar cortex during postnatal development following cisplatin treatment. Experimental Neurology 2006, 201:131-143.
7. Bailly Y., Haeberlé A.M., Blanquet-Grossard F., Chasserot-Golaz S., Grant N., Schultze T., Bombarde G., Grazzi J., Cesbron J.Y., Lemaire-Vieille C. Prion protein (PrPc) immunocytochemistry and expression of the green fluorescent protein reporter gene under control of the bovine PrP gene promoter in the mouse brain. Journal of Comparative Neurology 2004, 473:244-269.
8. Barmada S.J., Harris D.A. Visualization of prion infection in transgenic mice expressing green fluorescent protein-tagged prion protein. Journal of Neuroscience 2005, 25:5824-5832.
9. Bernocchi G., Bottone M.G., Piccolini V.M., Dal Bo V., Santin G., De Pascali S.A., Migoni D., Fanizzi F.P. Developing central nervous system and vulnerability to platinum compounds. Chemotherapy Research and Practice 2011, 2011:315418.
10. Bodenner D.L., Dedon P.C., Keng P.C., Borch R.F. Effect of diethyldithiocarbamate on cis-diamminedichloroplatinum(II)-induced cytotoxicity, DNA cross-linking, and gamma-glutamyl transpeptidase inhibition. Cancer Research 1986, 46:2745-2750.
11. Borchelt D.R., Koliatsos V.E., Guarnieri M., Pardo C.A., Sisodia S.S., Price D.L. Rapid anterograde axonal transport of the cellular prion glycoprotein in the peripheral and central nervous systems. Journal of Biological Chemistry 1994, 269:14711-14714.
12. Brown D.R., Schulz-Schaeffer W.J., Schmidt B., Kretzschmar H.A. Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Experimental Neurology 1997, 104-112.
13. Carleton A., Tremblay P., Vincent J.D., Lledo P.M. Dose-dependent, prion protein (PrP)-mediated facilitation of excitatory synaptic transmission in the mouse hippocampus. Pflügers Archiv 2001, 442:223-229.
14. Cerri S., Piccolini V.M., Santin G., Bottone M.G., De Pascali S.A., Migoni D., Iadarola P., Fanizzi F.P., Bernocchi G. The developmental neurotoxicity study of platinum compounds. Effects of cisplatin versus a novel Pt(II) complex on rat cerebellum. Neurotoxicology and Teratology 2011, 33:273-281.
15. Chiesa R., Harris D.A. Fishing for prion protein function. PLOS Biology 2009, 7:e1000075.
16. Collinge J., Whittington M.A., Sidle K.C., Smith C.J., Palmer M.S., Clarke A.R., Jefferys J.G. Prion protein is necessary for normal synaptic function. Nature 1994, 370:295-297.
17. Dietrich J., Han R., Yang Y., Mayer-Pröschel M., Noble M. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. Journal of Biology 2006, 5:22.
18. Eastman A. Analysis and quantitation of the DNA damage produced in cells by the cisplatin analog cis-[3H]dichloro(ethylenediamine)platinum(II). Analytical Biochemistry 1991, 197:311-315.
19. Farlie P.G., Dringen R., Rees S.M., Kannourakis G., Bernard O. bcl-2 transgene expression can protect neurons against developmental and induced cell death. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:4397-4401.
20. Harris D.A., True H.L. New insights into prion structure and toxicity. Neuron 2006, 50:353-537.
21. Horiuchi M., Yamazaki N., Ikeda T., Ishiguro N., Shinagawa M. A cellular form of prion protein (PrPC) exists in many non-neuronal tissues of sheep. Journal of General Virology 1995, 76:2583-2587.
22. Kim B.H., Lee H.G., Choi J.K., Kim J.I., Choi E.K., Carp R.I., Kim Y.S. The cellular prion protein (PrPC) prevents apoptotic neuronal cell death and mitochondrial dysfunction induced by serum deprivation. Brain Research: Molecular Brain Research 2004, 124:40-50.
23. Kuwahara C., Takeuchi A.M., Nishimura T., Haraguchi K., Kubosaki A., Matsumoto Y., Saeki K., Yokoyama T., Itohara S., Onodera T. Prions prevent neuronal cell-line death. Nature 1999, 400:225-226.
24. Lainé J., Marc M.E., Sy M.S., Axelrad H. Cellular and subcellular morphological localization of normal prion protein in rodent cerebellum. European Journal of Neuroscience 2001, 14:47-56.
25. Li A., Barmada S.J., Roth K.A., Harris D.A. N-terminally deleted forms of the prion protein activate both Bax-dependent and Bax-independent neurotoxic pathways. Journal of Neuroscience 2007, 27:852-859.
26. Li A., Christensen H.M., Stewart L.R., Roth K.A., Chiesa R., Harris D.A. Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105-125. EMBO Journal 2007, 26:548-558.
27. Mandic A., Hansson J., Linder S., Shoshan M.C. Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling. Journal of Biological Chemistry 2003, 278:9100-9106.
28. Martinou J.C., Dubois-Dauphin M., Staple J.K., Rodriguez I., Frankowski H., Missotten M., Albertini P., Talabot D., Catsicas S., Pietra C., Huarte J. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 1994, 13:1017-1030.
29. McWhinney S.R., Goldberg R.M., McLeod H.L. Platinum neurotoxicity pharmacogenetics. Molecular Cancer Therapeutics 2009, 8:10-16.
30. Mironov A., Latawiec D., Wille H., Bouzamondo-Bernstein E., Legname G., Williamson R.A., Burton D., DeArmond S.J., Prusiner S.N., Peters P.J. Cytosolic prion protein in neurons. Journal of Neuroscience 2003, 23:7183-7193.
31. Mouillet-Richard S., Ermonval M., Chebassier C., Laplanche J.L., Lehman S., Launay J.M., Kellermann O. Signal transduction through prion protein. Science 2000, 289:1925-1928.
32. Muscella A., Calabriso N., De Pascali S.A., Urso L., Ciccarese A., Fanizzi F.P., Migoni D., Marsigliante S. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells. Biochemical Pharmacology 2007, 74:28-40.
33. Muscella A., Calabriso N., Fanizzi F.P., De Pascali S.A., Urso L., Ciccarese A., Migoni D., Marsigliante S. [Pt(O,O'-acac)(gamma-acac)(DMS)], a new Pt compound exerting fast cytotoxicity in MCF-7 breast cancer cells via the mitochondrial apoptotic pathway. British Journal of Pharmacology 2008, 153:34-49.
34. Oltvai Z.N., Korsmeyer S.J. Checkpoints of dueling dimers foil death wishes. Cell 1994, 79:189-192.
35. Pauly P.C., Harris D.A. Copper stimulates endocytosis of the prion protein. Journal of Biological Chemistry 1998, 273:33107-33110.
36. Pisu M.B., Roda E., Guioli S., Avella D., Bottone M.G., Bernocchi G. Proliferation and migration of granule cells in the developing rat cerebellum: cisplatin effects. Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology 2005, 287:1226-1235.
37. Prestayko A.W., D'Aoust J.C., Issell B.F., Crooke S.T. Cisplatin (cis-diamminedichloroplatinum(II)). Cancer Treatment Reviews 1979, 6:17-39.
38. Prusiner S.B. Molecular biology and pathogenesis of prion diseases. Trends in Biochemical Sciences 1996, 21:482-487.
39. Prusiner S.B. Prions. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:13363-13383.
40. Qin L.F., Lee T.K., Ng I.O. Gene expression profiling by cDNA array in human hepatoma cell line in response to cisplatin treatment. Life Sciences 2002, 70:1677-1690.
41. Reed J.C. Bcl-2 and the regulation of programmed cell death. Journal of Cell Biology 1994, 124:1-6.
42. Rodolfo K., Hassig R., Moya K.L., Frobert Y., Grassi J., Di Giamberardino L. A novel cellular prion protein isoform present in rapid anterograde rapid transport. Neuroreport 1999, 10:3639-3644.
43. Roucou X., Giannopoulos P.N., Zhang Y., Jodoin J., Goodyer C.G., LeBlanc A. Cellular prion protein inhibits proapoptotic Bax conformational change in human neurons and in breast carcinoma MCF-7 cells. Cell Death and Differentiation 2005, 12:783-795.
44. Roucou X., LeBlanc A.C. Cellular prion protein neuroprotective function: implications in prion diseases. Journal of Molecular Medicine 2005, 83:3-11.
45. Salès N., Hassig R., Rodolfo K., Di Giamberardino L., Traiffort E., Ruat M., Frétier P., Moya K.L. Developmental expression of the cellular prion protein in elongating axons. European Journal of Neuroscience 2002, 15:1163-1177.
46. Salès N., Rodolfo K., Hassig R., Faucheux B., Di Giamberardino L., Moya K.L. Cellular prion protein localization in rodent and primate brain. European Journal of Neuroscience 1998, 10:2464-2471.
47. Scherini E., Bernocchi G. cisDDP treatment and development of the rat cerebellum. Progress in Neurobiology 1994, 42:161-196.
48. Schmitt-Ulms G., Legname G., Baldwin M.A., Ball H.L., Bradon N., Bosque P.J., Crossin K.L., Edelman G.M., DeArmond S.J., Cohen F.E., Prusiner S.B. Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. Journal of Molecular Biology 2001, 314:1209-1225.
49. Solforosi L., Criado J.R., McGavern D.B., Wirz S., Sanchez-Alavez M., Sugama S., De Giorgio L.A., Volpe B.T., Wiseman E., Abalos G., Masliah E., Gilden D., Oldstone M.B., Conti B., Williamson R.A. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 2004, 303:1514-1516.
50. Stahl N., Borchelt D.R., Hsiao K., Prusiner S.B. Scrapie prion protein contains a phosphatidyl-inositol glycolipid. Cell 1987, 51:229-240.
51. Stahl N., Prusiner S.B. Prions and prion proteins. FASEB Journal 1991, 5:2799-2807.
52. Vogel M.W. Cell death, Bcl-2, Bax, and the cerebellum. The Cerebellum 2002, 1:277-287.
53. Vorberg I., Priola S.A. Molecular basis of scrapie strain glycoform variation. Journal of Biological Chemistry 2002, 277:36775-36781.
54. Westergard L., Christensen H.M., Harris D.A. The cellular prion protein (PrPC): its physiological function and role in disease. Biochimica et Biophysica Acta 2007, 1772:629-644.
55. Wollmann M.J., Lindquist S. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 2002, 298:1781-1785.
56. Yang E., Korsmeyer S.J. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 1996, 88:386-401.
57. Yin X.M., Oltvai Z.N., Korsmeyer S.J. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 1994, 369:321-323.
58. Yuan J., Yankner B.A. Apoptosis in the nervous system. Nature 2000, 407:802-809.
59. Zhong L.T., Sarafian T., Kane D.J., Charles A.C., Mah S.P., Edwards R.H., Bredesen D.E. bcl-2 inhibits death of central neural cells induced by multiple agents. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:4533-4537.
60. Zomosa-Signoret V., Arnaud J.D., Fontes P., Alvarez-Martinez M.T., Liautard J.P. Physiological role of the cellular prion protein. Veterinary Research 2008, 39:09.